Mon, December 19, 2022
Fri, December 16, 2022
Thu, December 15, 2022
Wed, December 14, 2022
Tue, December 13, 2022

Andrea Tan Initiated (ABCL) at Strong Buy and Held Target at $30 on, Dec 15th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-30-on-dec-15th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrea Tan of Goldman Sachs, Initiated "AbCellera Biologics Inc." (ABCL) at Strong Buy and Held Target at $30 on, Dec 15th, 2022.

Andrea has made no other calls on ABCL in the last 4 months.



There are 2 other peers that have a rating on ABCL. Out of the 2 peers that are also analyzing ABCL, 0 agree with Andrea's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrea


  • Robyn Karnauskas of "Truist Securities" Initiated at Strong Buy and Held Target at $29 on, Wednesday, November 16th, 2022
  • Puneet Souda of "SVB Leerink" Maintained at Buy with Increased Target to $20 on, Wednesday, November 9th, 2022

Publication Contributing Sources